Alison J. McLean

708 total citations · 1 hit paper
10 papers, 576 citations indexed

About

Alison J. McLean is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Ecology. According to data from OpenAlex, Alison J. McLean has authored 10 papers receiving a total of 576 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Cellular and Molecular Neuroscience and 1 paper in Ecology. Recurrent topics in Alison J. McLean's work include Receptor Mechanisms and Signaling (9 papers), Neuropeptides and Animal Physiology (5 papers) and Neuroscience and Neuropharmacology Research (2 papers). Alison J. McLean is often cited by papers focused on Receptor Mechanisms and Signaling (9 papers), Neuropeptides and Animal Physiology (5 papers) and Neuroscience and Neuropharmacology Research (2 papers). Alison J. McLean collaborates with scholars based in United Kingdom, United States and Australia. Alison J. McLean's co-authors include Graeme Milligan, Ian McPhee, Robert J. Lefkowitz, George S. Baillie, Miles D. Houslay, Marco Conti, Kok Long Ang, Trudy A. Kohout, William E. Miller and Maria M. Magiera and has published in prestigious journals such as Science, British Journal of Pharmacology and Molecular Pharmacology.

In The Last Decade

Alison J. McLean

10 papers receiving 565 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targeting of Cyclic AMP Degradation to β ₂ -Adrenergic Receptors by β-Arrestins

2002 390 citations Stephen J. Perry, George S. Baillie et al. Science profile →

Peers

Countries citing papers authored by Alison J. McLean

Since Specialization

Citations

This map shows the geographic impact of Alison J. McLean's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison J. McLean with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison J. McLean more than expected).

Fields of papers citing papers by Alison J. McLean

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison J. McLean. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison J. McLean. The network helps show where Alison J. McLean may publish in the future.

Co-authorship network of co-authors of Alison J. McLean

This figure shows the co-authorship network connecting the top 25 collaborators of Alison J. McLean. A scholar is included among the top collaborators of Alison J. McLean based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison J. McLean. Alison J. McLean is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	G Protein-Coupled Receptor Fusion Proteins in Drug Discovery 2004 ·Current Pharmaceutical Design ·Graeme Milligan, Gui-Jie Feng, Richard J. Ward, (unknown), Douglas Ramsay, Alison J. McLean, Juan J. Carrillo	31
2	Ligand Specific Up-Regulation of a Renilla reniformis Luciferase-Tagged, Structurally Unstable Muscarinic M3 Chimeric G Protein-Coupled Receptor 2003 ·Molecular Pharmacology ·Fu‐Yue Zeng, Alison J. McLean, Graeme Milligan, Michael R. Lerner, Derek Chalmers, Dominic P. Behan	10
3	Targeting of Cyclic AMP Degradation to β ₂ -Adrenergic Receptors by β-Arrestins breakdown → 2002 ·Science ·Stephen J. Perry, George S. Baillie, Trudy A. Kohout, Ian McPhee, Maria M. Magiera, Kok Long Ang, William E. Miller, Alison J. McLean, Marco Conti, Miles D. Houslay, Robert J. Lefkowitz	390
4	Ligand Rescue of Constitutively Active Mutant Receptors 2002 ·Neurosignals ·Graeme Milligan, Patricia A. Stevens, Douglas Ramsay, Alison J. McLean	13
5	Generation and Analysis of Constitutively Active and Physically Destabilized Mutants of the Human β1-Adrenoceptor 2002 ·Molecular Pharmacology ·Alison J. McLean, Fu‐Yue Zeng, Dominic P. Behan, Derek Chalmers, Graeme Milligan	14
6	Ligand regulation of green fluorescent protein‐tagged forms of the human β₁‐ and β₂‐adrenoceptors; comparisons with the unmodified receptors 2000 ·British Journal of Pharmacology ·Alison J. McLean, Graeme Milligan	67
7	Diversity in the signalling and regulation of G-protein-coupled receptors 1999 ·Biochemical Society Transactions ·Graeme Milligan, D. Alex Groarke, Alison J. McLean, Richard J. Ward, Chee Wai Fong, A Cavalli, Tomáš Drmota	5
8	Visualizing Differences in Ligand Regulation of Wild-Type and Constitutively Active Mutant β₂-Adrenoceptor-Green Fluorescent Protein Fusion Proteins 1999 ·Molecular Pharmacology ·Alison J. McLean, Nicola Bevan, Stephen Edward Rees, Graeme Milligan	34
9	Visualizing Differences in Ligand Regulation of Wild-Type and Constitutively Active Mutant β2-Adrenoceptor-Green Fluorescent Protein Fusion Proteins 1999 ·Molecular Pharmacology ·Alison J. McLean, Nicola Bevan, (unknown), Graeme Milligan	7
10	A phosphatase of undefined function is common to the photoreceptive microvilli of several arthropod species 1989 ·Cell and Tissue Research ·(unknown), Alison J. McLean, (unknown), (unknown)	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact